How massive of a layoff would you predict? If we are at say 800 reps, impact would be at half of that? Less? More? Close up shop all together? I cant think of any companies that folded completely due to early generic competition. We could easily put out an authorized generic to combat against that while still promoting vascepa and its benefits knowing that any AB switch to a generic would likely favor a switch to our own generic, made from the same manufacturer with maybe slightly different packaging to save on costs at the wholesale level, while also keeping the same integrity and intellectual property of the branded version, which will ultimately make it harder for generic competitors to completely take our hard earned market share. Sure, we would still lose scripts to them, but dont we already lose scripts to omega 3s, fish oils supplements and fenofibrates? My point is, I dont think the impact will be as bad as you might think. Will it cause some growing pains, absolutely. But vascepa will only survive on the back of the sales team until we hit multi billion status. Then you can just let it do its thing. We have a long road ahead of us to even get to that point.
